Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 9/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26550939 | 0.86 | OPRK1 (0.44) | TMEM97KCNH2OPRK1EGFRSIGMAR1 | |
| SCHEMBL24348366 | 0.85 | TMEM97 (0.51) | TMEM97KCNH2SIGMAR1KDM4ETDP1 | |
| SCHEMBL26550804 | 0.84 | TMEM97 (0.39) | TMEM97KCNH2OPRK1SIGMAR1KDM4E | |
| SCHEMBL24348345 | 0.83 | OPRK1 (0.40) | TMEM97KCNH2OPRK1SIGMAR1 | |
| SCHEMBL26550869 | 0.82 | OPRK1 (0.40) | TMEM97KCNH2OPRK1SIGMAR1 | |
| SCHEMBL24349670 | 0.82 | OPRK1 (0.40) | TMEM97KCNH2OPRK1SIGMAR1 | |
| SCHEMBL26550783 | 0.81 | PRKAB2 (0.55) | TMEM97KCNH2OPRK1SIGMAR1KDM4E | |
| SCHEMBL24348939 | 0.81 | PTPN11 (0.40) | TMEM97KCNH2SIGMAR1KDM4ETDP1 | |
| SCHEMBL26550915 | 0.80 | MEN1 (0.39) | TMEM97KCNH2OPRK1SIGMAR1KDM4E | |
| SCHEMBL26550885 | 0.78 | TMEM97 (0.41) | TMEM97KCNH2OPRK1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329236-A1 | HERBICIDAL PYRIMIDINE DERIVATIVES | MOA Technology Limited (GB) | 2023-10-19 | — | — | US | disclosed |
| US-20230329236-A1 | HERBICIDAL PYRIMIDINE DERIVATIVES | MOA Technology Limited (GB) | 2023-10-19 | — | — | US | disclosed |
| WO-2022053803-A1 | HERBICIDAL PYRIMIDINE DERIVATIVES | MOA Technology Limited (GB) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329236-A1 | HERBICIDAL PYRIMIDINE DERIVATIVES | DPYD, XDH, DHX35 | TMEM97 3314/4885KCNH2 1025/4885OPRK1 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.